Thursday, June 9, 2011

Medicaid program gets $676K in pharmaceutical settlement - Denver Business Journal:

ukatekexo.wordpress.com
Paris-based reached a $182.8 millionm settlement with all 50 statesxand Washington, D.C., after attorneyds general nationwide mounted an investigation into the company'se alleged overbilling for Anzemet, an anti-nauseai drug typically used in chemotherapty treatments. Ohio Attorney General Marc Dann and othe r officials claim the company inflated averagde wholesale prices forthe drug. "My officee will continue to look into the pharmaceutical industry to make sure no other company is takint advantage of the systemor Ohioans," Dann said in a Dann is involved in similare lawsuits pending against Columbus-based , Abbott Park, Ill.-basesd (NYSE:ABT), Peapack, N.J.
-based and Reno, Nev.-based The federalk government's Medicare program is receivinhg $160.1 million of the Aventis while the rest will be funnelef to state Medicaid programs. Officials at the company, now namec (NYSE:SNY), couldn't be reached immediately for Ohio's Medicaid program, started in assists 1.7 million Ohioans a monthn on average, and about 2.2 milliomn throughout the year. The $13.3 billion program, which takeas up about a quarter ofthe state's annual serves children and adults in low-income Ohio families.

No comments:

Post a Comment